What factors determine the pregnancy outcome in patients with essential thrombocythemia?

References

• Paydas S. Management of hemopoietic neoplasias during pregnancy. Crit Rev Oncol Hematol. 2016;104:52–64.
   PubMed Web of Science ®Google Scholar
• Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279–287.
   PubMed Web of Science ®Google Scholar
• El-Messidi A, Patenaude V, Abenhaim HA. Incidence and outcomes of women with non-Hodgkin's lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res. 2015;41(4):582–589.
   PubMed Web of Science ®Google Scholar
• Mahmoud HK, Samra MA, Fathy GM. Hematologic malignancies during pregnancy: a review. J Adv Res. 2016;7(4):589–596.
   PubMed Web of Science ®Google Scholar
• Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011;20(4):e175–e185.
   PubMed Web of Science ®Google Scholar
• Chen Q, Lu P, Jones AV, et al. Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders. J Mol Diagn. 2007;9(2):272–276.
   PubMed Web of Science ®Google Scholar
• Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379–2390.
   PubMed Web of Science ®Google Scholar
• Ghaderi M, Strömberg O, Porwit A. Rapid real-time PCR assay for detection of MPL W515L mutation in patients with chronic myeloproliferative disorders. Int J Lab Hematol. 2010;32(1 Pt 2):122–126.
   PubMed Web of Science ®Google Scholar
• Passamonti F, Thiele J, Girodon F, et al. A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on myelofibrosis research and treatment. Blood. 2012;9120(6):1197–1201.
   PubMed Web of Science ®Google Scholar
• Barbui T, Finazzi G, Carobbio A, et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012;120(26):5128–5133.
   PubMed Web of Science ®Google Scholar
• Harrison CN, Campbell PJ, Buck G, et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005;353(1):33–45.
   PubMed Web of Science ®Google Scholar
• Harrison CN. Essential thrombocythaemia: challenges and evidence-based management. Br J Haematol. 2005;130(2):153–165.
   PubMed Web of Science ®Google Scholar
• Barbui T, Barosi G, Grossi A, et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation. Haematologica. 2004;89(2):215–232.
   PubMed Web of Science ®Google Scholar
• Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;(10):CD004659.
   Web of Science ®Google Scholar
• Alvarez-Larrán A, Pereira A, Guglielmelli P, et al. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation. Haematologica. 2016;101(8):926–931.
   PubMed Web of Science ®Google Scholar
• Gris J-C, Mercier E, Quéré I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103(10):3695–3699.
   PubMed Web of Science ®Google Scholar
• Barbui T, Barosi G, Birgegard G, European LeukemiaNet, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761–770.
   PubMed Web of Science ®Google Scholar
• Lavi N, Brenner B, Avivi I. Management of pregnant women with myeloproliferative neoplasms. Thromb Res. 2013;131(Suppl 1):S11–S3.
   PubMedGoogle Scholar
• Law AD, Dong Hwan Kim D, Lipton JH. Pregnancy: part of life in chronic myelogenous leukemia. Leuk Lymphoma. 2017;58(2):280–287.
   PubMed Web of Science ®Google Scholar
• Baer MR, Ozer H, Foon KA. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol. 1992;81(2):167–169.
   PubMed Web of Science ®Google Scholar
• Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009;84(12):830–841.
   PubMed Web of Science ®Google Scholar
• Baer MR. Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with alpha-interferon. Am J Hematol. 1991;37(1):66.
   PubMed Web of Science ®Google Scholar
• Shpilberg O, Shimon I, Sofer O, et al. Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia. Br J Haematol. 1996;92(2):491–493.
   PubMed Web of Science ®Google Scholar
• Melillo L, Tieghi A, Candoni A, et al. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. Am J Hematol. 2009;84(10):636–640.
   PubMed Web of Science ®Google Scholar
• Bangerter M, Güthner C, Beneke H, et al. Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. Eur J Haematol. 2000;65(3):165–169.
   PubMed Web of Science ®Google Scholar
• Passamonti F, Randi ML, Rumi E, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V > F) mutation. Blood. 2007;110(2):485–489.
   PubMed Web of Science ®Google Scholar
• Rumi E, Bertozzi I, Casetti IC, Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, et al. Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia. Haematologica. 2015;100(11):e443–e445.
   PubMed Web of Science ®Google Scholar
• Magnus MC, Wilcox AJ, Morken NH, et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869.
   PubMed Web of Science ®Google Scholar
• Lin YH, Chen KJ, Peng YS, et al. Type 1 diabetes impairs female fertility even before it is diagnosed. Diabetes Res Clin Pract. 2018;143:151–158.
   PubMed Web of Science ®Google Scholar
• McNamee K, Dawood F, Farquharson RG. Thrombophilia and early pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):91–102.
   PubMed Web of Science ®Google Scholar